Article History
Accepted: 17 May 2023
First Online: 8 June 2023
Declarations
:
: Dr. Kostenuik reports past and/or current consulting relationships and previous employment with Amgen and Radius Health, and consulting relationships with Mesentech Inc, AbbVie, Ascendis, Beren, UCB, Myovant, and Angitia Biopharmaceuticals. Dr. Kostenuik is also the CEO and co-founder of Ortheus Inc., with patents pending. Dr. Binkley reports research support to his institution from Radius Health and Amgen, and consulting for Amgen. Dr. Anderson reports personal fees from Amgen, Radius Medical, and Medtronic; grant support from Radius Medical; and stock in Titan Spine. Radius Health sponsored open access. This article received no other industry support or input and reflects the authors’ independent opinions and interpretations.